CorWave Inaugurates State-of-the-Art Manufacturing Facility Along the Seine River Near Paris

Tuesday, October 10, 2023

CorWave, a French company specializing in the development and manufacturing of innovative cardiac assist devices, has officially opened its new facility located along the Seine River in Clichy, near Paris. The facility, spanning more than 2,400 square meters, encompasses production, laboratory, and office spaces, serving as the central hub for the company's headquarters, research and development center, and its initial manufacturing facility spanning nearly 1,000 square meters. This state-of-the-art manufacturing facility has been strategically established to support the clinical trial phase and facilitate commercial scaling.

CorWave's urban factory is exclusively dedicated to the production and assembly of heart pump systems. The grand opening event was attended by notable figures, including Roland Lescure, Minister Delegate for Industry, and Jean-Noël Barrot, Minister Delegate for the Digital Sector.

Founded in 2012, CorWave's core mission is to provide healthcare professionals with innovative cardiac assist devices that can save heart failure patients and improve their quality of life.

The facility features world-class equipment and layout, with two primary areas designed for efficient and controlled operations. The first area houses high-precision CNC machining centers for the precise manufacturing of components essential for heart pump development. The second area is dedicated to heart pump system production and includes an ISO 7 cleanroom for a clean and controlled assembly environment, a specialized inspection area for rigorous quality control of parts and assemblies, and high-density warehousing storage for components and finished products.

The facility aligns with CorWave's vision to become a world-class medtech company specializing in next-generation cardiac pumps based on undulating membrane pump technology. It has the capacity to produce up to 1,000 pumps annually, with potential sales estimated at around €100 million. Furthermore, there is potential for future expansion at the same site, which could increase production capacity to 10,000 pumps per year, potentially representing sales of approximately €1 billion.

Michael Webb, Vice President of Manufacturing at CorWave, emphasized the significant milestone of the facility's opening in advancing CorWave's mission to assist heart failure patients, acknowledging the collaborative efforts of all involved.

Louis de Lillers, CEO of CorWave, expressed his satisfaction with achieving this strategic step. He highlighted the company's decision to establish its presence in Greater Paris, specifically in Clichy, to be in close proximity to talent and to consolidate Research & Development and production under one roof. The company's journey symbolizes the ongoing reindustrialization efforts, aimed at supporting healthcare professionals in saving heart failure patients and enhancing their quality of life.



Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital Congress